Targeted Oncology1h
5-Year Update Sustains Nivolumab/Chemo Efficacy in Frontline Gastric/GEJ/Esophageal Cancer
CheckMate 649 trial showed sustained efficacy with frontline nivolumab plus chemotherapy vs chemotherapy alone in patients with gastric cancers.
At 30 years old, my pregnancy gave me cancer. Here’s how it happened
My miscarriage led to an "interesting" finding, doctors said, which is never a word you want to hear about your health.
muddyrivernews5h
Memorial Hospital recognized by Becker’s Review among top U.S. hospitals for patient recommendations
CMS evaluates hospitals using 10 HCAHPS star ratings, one of which is the patient's response to the critical question "Would you recommend this hospital to your friends and family?" To qualify for a s ...
MULTICARE HOSPITAL WORKERS IN YAKIMA ORGANIZE WITH TEAMSTERS
Workers at MultiCare Yakima Memorial Hospital voted overwhelmingly to join Teamsters Local 760. The new Teamsters work as ...
manilatimes8h
ORYZON announces first patient dosed in an Investigator-initiated Phase I study of iadademstat in myelodysplastic syndrome
Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today ...
TMCnet8h
SELLAS Life Sciences Announces Positive Outcome of Interim Analysis for its Pivotal Phase 3 REGAL Trial of GPS in Acute Myeloid Leukemia
These data are consistent with previous GPS trials. In the Phase 2 study in AML patients in second complete remission, the median overall survival of GPS-treated patients was 21 months versus 5.4 ...
A grim prognosis, a gamble and one patient’s fight to defy cancer
After a Stage 4 cancer diagnosis and a prognosis of 16 months to live, Katie Doble didn’t know whether she should plan her ...